TSHA-120 Earns Orphan Drug Designation in Europe for Giant Axonal Neuropathy
In Europe, Orphan Drug designation is granted to drugs or biologics intended to treat, diagnose, or prevent rare, life-threatening, or chronically debilitating conditions. For the European Union (EU), a “rare”…